Overview
What is Oligonucleotide Therapeutics Society?
The Oligonucleotide Therapeutics Society is an educational organization based in San Diego, California. Their primary focus is to foster discussions on oligonucleotide research and therapeutics development. They achieve this through their four-day professional meetings, where experts from various fields present their findings. These presentations are selected based on submitted abstracts and cover both short and long topics. The society also hosts between 160-175 poster presentations, showcasing current research in the industry. Networking opportunities are provided during these poster sessions, and awards are given to outstanding posters. Additionally, travel grants and scholarships are offered annually to support the society's members and promote growth in the field.
Official website here: www.oligotherapeutics.org
Is Oligonucleotide Therapeutics Society legitimate?
Oligonucleotide Therapeutics Society is a legitimate nonprofit organization registered as a 501(c)(6) entity. Oligonucleotide Therapeutics Society submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.oligotherapeutics.org
What is the mission statement of Oligonucleotide Therapeutics Society?
The Oligonucleotide Therapeutics Society serves as an educational organization, dedicated to fostering discussions on oligonucleotide research and therapeutics development. Its mission is to create a platform for industry professionals, academics, and students to share their findings and advancements in the field. The society achieves this through a four-day professional meeting, featuring scientific presentations and poster sessions, where researchers present their current research and findings. The program committee, composed of various stakeholders, ensures the content is relevant, current, and of interest to the society's membership base. Awards and travel grants are also offered to recognize and support outstanding contributions in the field.
Official website here: www.oligotherapeutics.org
What is the revenue of Oligonucleotide Therapeutics Society?
Oligonucleotide Therapeutics Society's revenue in 2024 was $1,653,140.
Official website here: www.oligotherapeutics.org
Who are the executives of Oligonucleotide Therapeutics Society and what are their salaries?
There 39 volunteers at Oligonucleotide Therapeutics Society.
Here are 25 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.oligotherapeutics.org
Where can I find the form 990 for Oligonucleotide Therapeutics Society?
Oligonucleotide Therapeutics Society's most recent form 990 was submitted in 2024 and can be accessed here.
Official website here: www.oligotherapeutics.org
Learn more at the official website: www.oligotherapeutics.org
Mission Statement of Oligonucleotide Therapeutics Society
The Oligonucleotide Therapeutics Society, an educational organization, is devoted to fostering discussions surrounding oligonucleotide research and therapeutics development. Its primary mission is to serve as a platform for sharing knowledge, with a focus on scientific presentations from various sectors, including industry, academia, and students. The society's program is structured around a four-day professional meeting, featuring presentations in both short and long formats. These presentations showcase the latest research and developments in the field, selected through a rigorous process involving both invitations and abstract reviews.
The program committee, composed of experts from the society's membership base, ensures that the content is current, relevant, and of interest to all constituent groups. The meeting also includes a significant number of poster presentations, offering attendees the opportunity to network and engage with researchers in the field. Awards are given to recognize outstanding posters and abstracts, as well as to support travel and education for students and professionals in the field. The society also honors individuals with a Lifetime Achievement Award, recognizing their significant contributions to oligonucleotide therapeutics. In summary, the Oligonucleotide Therapeutics Society plays a crucial role in promoting collaboration, knowledge sharing, and advancements in the field of oligonucleotide research and therapeutics development.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Oligonucleotide Therapeutics Society significantly contributes to the field of oligonucleotide research and therapeutics development through its annual meetings and educational programs. These events facilitate knowledge exchange among industry professionals, academics, and students, fostering collaboration and innovation.
The four-day professional meeting showcases a diverse range of scientific presentations, including both short and long sessions based on rigorously evaluated abstracts. This format not only highlights current research but also encourages networking opportunities among attendees. The extensive poster presentation sessions further enhance interaction, allowing participants to discuss cutting-edge topics and connect directly with researchers.
The Society also recognizes outstanding contributions to the field through awards for the best posters and abstracts, as well as annual scholarships and travel grants, which support the next generation of researchers. The Lifetime Achievement Award honors exceptional individuals whose work has left a lasting impact on the community.
Overall, the Oligonucleotide Therapeutics Society plays a critical role in advancing the understanding and development of oligonucleotide therapies, promoting scientific excellence, and building a vibrant professional network in this rapidly evolving area of medical research.
This information is meant to be a general summary of Oligonucleotide Therapeutics Society. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2024.
- Investment Income: $14,624
- Program Service Revenue: $1,633,291
- Gross Receipts: $1,653,140
Assets and Liabilities:
- Total Assets: $1,817,748
- Total Liabilities: $0
- Net Assets: $1,817,748
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CLOSING EVENT
Revenue
$32,050
MEMBERSHIP DUES
Revenue
$59,796
PROGRAM REGISTRATION
Revenue
$951,908
PROGRAM SPONSORSHIP
Revenue
$569,851
PUBLISHER AGREEMENT
Revenue
$19,686
Organization Details
Founding Year
2002
Principal Officer
Richard Geary
Website
www.oligotherapeutics.orgNTEE Category
Code: H99 - Medical research
If you are a representative of Oligonucleotide Therapeutics Society and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.